PGHH

Procter & Gamble Hygiene and Health Care Limited

Feminine hygiene and healthcare products under Whisper and Vicks brands

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products›Personal Care

us.pg.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-19

Stock price
₹7148.50
Market cap
23,204 Cr
Stock P/E
29.3
P/B
30.80
Dividend yield
3.6%
ROE (FY26)
113.7%
ROCE (FY26)
156.1%
Operating margin (FY26)
26.4%
OCF / EBITDA (FY26)
78.9%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

PGHH (Procter & Gamble Hygiene and Health Care) sells feminine hygiene and healthcare products to Indian consumers, led by the Whisper and Vicks brands, which the company describes as India's leading feminine hygiene brand and India's No. 1 healthcare brand.

Company snapshot

6thBy market cap

Ranked among 10 companies in Personal Care.

What we see

Positives
  • ✓Net margin of 20.0% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,138 Cr1,133 Cr1,002 Cr932 Cr1,135 Cr1,248 Cr992 Cr937 Cr1,150 Cr1,262 Cr941 Cr891 Cr
Operating expenses (approx.)853 Cr824 Cr745 Cr813 Cr845 Cr877 Cr782 Cr671 Cr865 Cr860 Cr723 Cr721 Cr
EBITDA285 Cr310 Cr257 Cr118 Cr290 Cr371 Cr210 Cr266 Cr285 Cr402 Cr218 Cr170 Cr
OPM %25.0%27.3%25.7%12.7%25.6%29.7%21.1%28.4%24.8%31.8%23.2%19.1%
Other income16 Cr16 Cr14 Cr7 Cr9 Cr10 Cr19 Cr8 Cr10 Cr12 Cr12 Cr9 Cr
Interest2 Cr3 Cr22 Cr-0.08 Cr2 Cr7 Cr6 Cr0.07 Cr4 Cr3 Cr3 Cr0.27 Cr
Depreciation14 Cr14 Cr15 Cr13 Cr12 Cr10 Cr10 Cr9 Cr9 Cr10 Cr10 Cr10 Cr
Profit before tax284 Cr309 Cr234 Cr112 Cr285 Cr364 Cr213 Cr265 Cr282 Cr402 Cr218 Cr170 Cr
Tax %25.9%25.8%34.0%27.8%25.7%26.2%26.6%27.4%25.5%25.0%29.8%25.6%
Net profit211 Cr229 Cr154 Cr81 Cr212 Cr269 Cr156 Cr192 Cr210 Cr301 Cr153 Cr126 Cr
EPS (₹)₹64.91₹70.51₹47.56₹24.97₹65.28₹82.74₹48.09₹59.17₹64.65₹92.87₹47.17₹38.90

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2026TTM
Sales2,419 Cr2,455 Cr2,947 Cr3,002 Cr3,574 Cr3,901 Cr3,918 Cr4,206 Cr4,290 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,755 Cr1,840 Cr2,337 Cr2,398 Cr2,690 Cr3,071 Cr3,049 Cr3,235 Cr3,119 CrSign in free for the trailing twelve months
EBITDA665 Cr615 Cr609 Cr604 Cr884 Cr830 Cr869 Cr970 Cr1,171 CrSign in free for the trailing twelve months
OPM %27.5%25.1%20.7%20.1%24.7%21.3%22.2%23.1%27.3%Sign in free for the trailing twelve months
Other income77 Cr24 Cr53 Cr44 Cr39 Cr24 Cr41 Cr52 Cr42 CrSign in free for the trailing twelve months
Interest10 Cr5 Cr5 Cr6 Cr6 Cr11 Cr11 Cr27 Cr9 CrSign in free for the trailing twelve months
Depreciation60 Cr52 Cr50 Cr48 Cr48 Cr53 Cr58 Cr57 Cr37 CrSign in free for the trailing twelve months
Profit before tax672 Cr582 Cr607 Cr594 Cr870 Cr790 Cr839 Cr939 Cr1,167 CrSign in free for the trailing twelve months
Tax %35.6%35.6%31.0%27.1%25.1%27.1%19.2%28.1%26.6%Sign in free for the trailing twelve months
Net profit433 Cr375 Cr419 Cr433 Cr652 Cr576 Cr678 Cr675 Cr857 CrSign in free for the trailing twelve months
EPS (₹)₹133.31₹115.40₹129.12₹133.42₹200.79₹177.37₹208.91₹207.95₹263.86Sign in free for the trailing twelve months
Dividend payout %————169.3%98.7%69.4%127.4%98.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2026
Equity capital32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr32 Cr
Reserves494 Cr773 Cr877 Cr1,125 Cr682 Cr705 Cr914 Cr742 Cr721 Cr
Borrowings—————————
Other liabilities634 Cr620 Cr723 Cr671 Cr918 Cr944 Cr1,191 Cr1,084 Cr1,050 Cr
Total liabilities1,160 Cr1,425 Cr1,632 Cr1,828 Cr1,633 Cr1,681 Cr2,137 Cr1,859 Cr1,804 Cr
Fixed assets (net)286 Cr250 Cr234 Cr207 Cr184 Cr164 Cr170 Cr139 Cr163 Cr
CWIP41 Cr21 Cr15 Cr22 Cr38 Cr44 Cr23 Cr28 Cr21 Cr
Investments—0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances—99 Cr101 Cr6 Cr6 Cr6 Cr4 Cr4 Cr5 Cr
Inventories177 Cr124 Cr203 Cr205 Cr249 Cr234 Cr220 Cr226 Cr218 Cr
Trade receivables133 Cr148 Cr181 Cr166 Cr142 Cr191 Cr216 Cr241 Cr243 Cr
Cash & bank102 Cr392 Cr526 Cr884 Cr648 Cr625 Cr964 Cr574 Cr557 Cr
Other assets421 Cr390 Cr372 Cr338 Cr366 Cr418 Cr541 Cr648 Cr596 Cr
Total assets1,160 Cr1,425 Cr1,632 Cr1,828 Cr1,633 Cr1,681 Cr2,137 Cr1,859 Cr1,804 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2026
Cash from operating activity445 Cr415 Cr412 Cr474 Cr863 Cr573 Cr826 Cr471 Cr924 Cr
Cash from investing149 Cr-19 Cr35 Cr75 Cr7 Cr-27 Cr-10 Cr1 Cr11 Cr
Cash from financing-1,559 Cr-106 Cr-314 Cr-191 Cr-1,106 Cr-569 Cr-477 Cr-862 Cr-845 Cr
Net cash flow-964 Cr290 Cr134 Cr358 Cr-236 Cr-23 Cr339 Cr-390 Cr91 Cr
Free cash flow (OCF − Capex)401 Cr381 Cr396 Cr423 Cr832 Cr523 Cr781 Cr426 Cr924 Cr

Ratios

MetricJun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2026
ROCE %129.7%72.9%67.4%51.8%122.6%108.6%89.9%124.7%156.1%
ROE %82.2%46.5%46.1%37.4%91.3%78.1%71.7%87.1%113.7%
Debtor days202222201418202121
Inventory days105837870806894107107
Days payable216271210182243225417403417
Cash conversion cycle-90-167-109-91-148-139-303-275-288
OCF / EBITDA %67.0%67.5%67.6%78.5%97.6%69.1%95.1%48.5%78.9%
OCF / EBITDA % (3 years)——67.4%71.2%83.4%82.4%87.6%70.0%—
Debt / equity———0.00—————
Current ratio0.961.511.632.221.341.321.381.221.22
Net debt / EBITDA-0.15-0.64-0.86-1.46-0.73-0.75-1.11-0.59-0.48